1 Introduction Catalytic nanomaterials are increasingly recognized as powerful platforms for biomedical applications, where controlled generation of reactive oxygen species (ROS) can impose oxidative stress, disrupt tumor redox homeostasis, and enhance therapeutic efficacy [1, 2]. ROS-driven nanocatalysts underpin a range of modalities, including photodynamic therapy, chemodynamic therapy, and enzyme-mimicking systems, offering prospects for targeted cancer therapy [3].
Min Ko
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Min
Contact Min, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack